PT1474443E - Péptidos tolerogénicos da proteína básica da mielina - Google Patents
Péptidos tolerogénicos da proteína básica da mielina Download PDFInfo
- Publication number
- PT1474443E PT1474443E PT03701612T PT03701612T PT1474443E PT 1474443 E PT1474443 E PT 1474443E PT 03701612 T PT03701612 T PT 03701612T PT 03701612 T PT03701612 T PT 03701612T PT 1474443 E PT1474443 E PT 1474443E
- Authority
- PT
- Portugal
- Prior art keywords
- peptide
- peptides
- cell
- antigen
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0202399.2A GB0202399D0 (en) | 2002-02-01 | 2002-02-01 | Peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1474443E true PT1474443E (pt) | 2010-10-26 |
Family
ID=9930251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03701612T PT1474443E (pt) | 2002-02-01 | 2003-01-30 | Péptidos tolerogénicos da proteína básica da mielina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7071297B2 (de) |
| EP (1) | EP1474443B1 (de) |
| JP (1) | JP4559082B2 (de) |
| KR (1) | KR20040108650A (de) |
| CN (1) | CN100482685C (de) |
| AT (1) | ATE477269T1 (de) |
| AU (1) | AU2003202701B2 (de) |
| BR (1) | BRPI0307276B8 (de) |
| CA (1) | CA2473469C (de) |
| CO (1) | CO5601035A2 (de) |
| CY (1) | CY1110862T1 (de) |
| DE (1) | DE60333728D1 (de) |
| DK (1) | DK1474443T3 (de) |
| ES (1) | ES2349463T3 (de) |
| GB (1) | GB0202399D0 (de) |
| HK (1) | HK1066551A1 (de) |
| MX (1) | MXPA04007510A (de) |
| NO (1) | NO332446B1 (de) |
| NZ (1) | NZ534233A (de) |
| PL (1) | PL212129B1 (de) |
| PT (1) | PT1474443E (de) |
| SI (1) | SI1474443T1 (de) |
| WO (1) | WO2003064464A1 (de) |
| ZA (1) | ZA200405546B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764425B (zh) | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
| EP2134176A4 (de) * | 2007-03-30 | 2012-08-29 | Brigham & Womens Hospital | Verbindungen und verfahren zur verbesserung von mhc-klasse-ii-therapien |
| WO2009056833A2 (en) | 2007-10-31 | 2009-05-07 | Apitope Technology (Bristol) Limited | Composition |
| WO2011046462A1 (en) | 2009-10-12 | 2011-04-21 | Angport Limited | Composition for treatment of multiple sclerosis |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| CA2807942C (en) | 2010-08-10 | 2021-07-27 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| GB201314052D0 (en) | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| US10046056B2 (en) * | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| AU2015233084B2 (en) | 2014-02-21 | 2020-12-17 | Anokion Sa | Glycotargeting therapeutics |
| JP7117847B2 (ja) * | 2014-12-24 | 2022-08-15 | アピトープ インターナショナル エヌブイ | 組成物 |
| EP3344575B1 (de) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intrazelluläres einbringen von biomolekülen in zellen mit einer zellwand |
| CA3049177A1 (en) * | 2017-01-04 | 2018-07-12 | Apitope Technology (Bristol) Limited | Therapeutic method using tolerogenic peptides |
| WO2018232176A1 (en) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| CN110317254A (zh) * | 2018-03-28 | 2019-10-11 | 深圳市安群生物工程有限公司 | 人mbp抗原表位肽、抗原、抗体、应用及化学发光试剂盒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858980A (en) * | 1990-03-30 | 1999-01-12 | Autoimmune, Inc. | Peptide fragments of myelin basic protein |
| WO1995030435A2 (en) * | 1994-05-10 | 1995-11-16 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
| IL115766A0 (en) * | 1994-10-25 | 1996-01-19 | Immulogic Pharma Corp | Composition and treatment for multiple sclerosis |
| CN102764425B (zh) * | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
-
2002
- 2002-02-01 GB GBGB0202399.2A patent/GB0202399D0/en not_active Ceased
-
2003
- 2003-01-30 BR BRPI0307276A patent/BRPI0307276B8/pt not_active IP Right Cessation
- 2003-01-30 NZ NZ534233A patent/NZ534233A/en not_active IP Right Cessation
- 2003-01-30 ES ES03701612T patent/ES2349463T3/es not_active Expired - Lifetime
- 2003-01-30 KR KR10-2004-7011906A patent/KR20040108650A/ko not_active Application Discontinuation
- 2003-01-30 DE DE60333728T patent/DE60333728D1/de not_active Expired - Lifetime
- 2003-01-30 PT PT03701612T patent/PT1474443E/pt unknown
- 2003-01-30 MX MXPA04007510A patent/MXPA04007510A/es active IP Right Grant
- 2003-01-30 CN CNB038030772A patent/CN100482685C/zh not_active Expired - Fee Related
- 2003-01-30 JP JP2003564084A patent/JP4559082B2/ja not_active Expired - Fee Related
- 2003-01-30 PL PL371549A patent/PL212129B1/pl unknown
- 2003-01-30 AT AT03701612T patent/ATE477269T1/de active
- 2003-01-30 DK DK03701612.8T patent/DK1474443T3/da active
- 2003-01-30 SI SI200331890T patent/SI1474443T1/sl unknown
- 2003-01-30 WO PCT/GB2003/000399 patent/WO2003064464A1/en active Application Filing
- 2003-01-30 AU AU2003202701A patent/AU2003202701B2/en not_active Ceased
- 2003-01-30 CA CA2473469A patent/CA2473469C/en not_active Expired - Lifetime
- 2003-01-30 EP EP03701612A patent/EP1474443B1/de not_active Expired - Lifetime
-
2004
- 2004-07-13 ZA ZA2004/05546A patent/ZA200405546B/en unknown
- 2004-07-27 US US10/900,032 patent/US7071297B2/en not_active Expired - Lifetime
- 2004-07-28 NO NO20043210A patent/NO332446B1/no not_active IP Right Cessation
- 2004-08-26 CO CO04083647A patent/CO5601035A2/es not_active Application Discontinuation
- 2004-11-27 HK HK04109379.8A patent/HK1066551A1/xx not_active IP Right Cessation
-
2010
- 2010-10-27 CY CY20101100972T patent/CY1110862T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1474443T1 (sl) | 2010-12-31 |
| DK1474443T3 (da) | 2010-10-18 |
| NO20043210L (no) | 2004-11-01 |
| GB0202399D0 (en) | 2002-03-20 |
| BRPI0307276B8 (pt) | 2021-05-25 |
| US20050058643A1 (en) | 2005-03-17 |
| ATE477269T1 (de) | 2010-08-15 |
| NZ534233A (en) | 2006-04-28 |
| CO5601035A2 (es) | 2006-01-31 |
| HK1066551A1 (en) | 2005-03-24 |
| ZA200405546B (en) | 2005-09-28 |
| CA2473469C (en) | 2012-04-24 |
| CY1110862T1 (el) | 2015-06-10 |
| PL371549A1 (en) | 2005-06-27 |
| AU2003202701B2 (en) | 2009-01-08 |
| WO2003064464A1 (en) | 2003-08-07 |
| BRPI0307276B1 (pt) | 2019-08-13 |
| JP4559082B2 (ja) | 2010-10-06 |
| ES2349463T3 (es) | 2011-01-03 |
| EP1474443B1 (de) | 2010-08-11 |
| KR20040108650A (ko) | 2004-12-24 |
| DE60333728D1 (de) | 2010-09-23 |
| NO332446B1 (no) | 2012-09-17 |
| MXPA04007510A (es) | 2005-07-13 |
| CN100482685C (zh) | 2009-04-29 |
| BR0307276A (pt) | 2004-12-14 |
| JP2005531497A (ja) | 2005-10-20 |
| EP1474443A1 (de) | 2004-11-10 |
| CA2473469A1 (en) | 2003-08-07 |
| US7071297B2 (en) | 2006-07-04 |
| PL212129B1 (pl) | 2012-08-31 |
| CN1625564A (zh) | 2005-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180311328A1 (en) | Peptide Selection Method | |
| PT1474443E (pt) | Péptidos tolerogénicos da proteína básica da mielina | |
| AU2001278637A1 (en) | Peptide selection method | |
| JP6063402B2 (ja) | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 | |
| AU2003202701A1 (en) | Tolerogenic peptides from myelin basic protein | |
| JP2010235607A (ja) | 自己免疫疾患の診断薬と治療薬となるペプチド類 | |
| AU2006203165B2 (en) | Peptide selection method | |
| Shen et al. | Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse |